Country intelligence
Deals, market moves, science and policy across the platform tagged to Denmark.
A pilot becoming permanent — and a significant European producer and exporter.
Market sizing, forecasts, pricing and patient data are available to Prohibition Partners subscribers. View on Prohibition Partners →
The Danish Medicines Agency licenses cultivation, bulk, extracts and exports under continuous EU-GMP inspection, with different permits for primary versus intermediate products. The 2018 pilot is being made permanent.
All doctors can prescribe under the pilot, for indications including MS and spinal spasms, chemotherapy nausea and neuropathic pain.
Terminally ill patients are fully reimbursed; other patients receive partial reimbursement up to an annual cap, paying the remainder themselves.
A small number of pilot-scheme flower products, all imported from the Netherlands, and several extracts are available.
Denmark is a leading exporter, supplying Germany, a growing Australian market and the UK; flowers are imported from the Netherlands while extracts come from Canada, New Zealand and domestic producers.
A licensed base of cultivation and processing companies supports the export sector.
Nothing tagged to Denmark yet. Tag deals, studies or articles with this country to see them here and on the map.
